Update on macrophage clearance of inhaled micro- and nanoparticles
- PMID: 20109124
- DOI: 10.1089/jamp.2009.0797
Update on macrophage clearance of inhaled micro- and nanoparticles
Abstract
Background: Lung macrophages, that is, the intravascular, interstitial, pleural, and surface macrophages, are part of the mononuclear phagocyte system. They are derived from the hematopoietic stem cell in the bone marrow with the monocytes as their putative precursors. Macrophages residing on the inner surfaces of the lungs and immersed within the lung lining layer, that is, the alveolar and the airway macrophages, are constantly exposed to the environment; it is those cells that are recognized as first line of cellular host defense.
Methods and results: Phagocytic uptake of inhaled and deposited particles is the main mechanism to remove insoluble micrometer-sized particles from the lung surfaces, where mucociliary transport, cough, or sneezing fail or are absent. Phagocytosis requires an intact cytoskeleton and is most efficient when mediated by Fc-receptors, but complement and scavenger receptors like MARCO and CD206 are just as important. The main pathway for the clearance of macrophage-associated particles is by mucociliary transport; to a lesser degree and species specific, particle-containing macrophages may reenter into the interstitium and go from there to the lymphatics. Inhaled nanometer-sized particles that deposit along the entire respiratory tract, however, are not efficiently phagocytosed by surface macrophages.
Conclusions: Uptake by spontaneous or stimulated (macro-) pinocytosis or electrokinetic's phenomena may become more important. In addition, translocation of nanometer-sized particles into the interstitium and to the blood circulation brings them into contact with other fluids; altered particle properties may influence particle uptake. Moreover, translocated particles may interact with lung macrophage populations that were previously not considered of great significance for the clearance of inhaled particles.
Similar articles
-
Role of alveolar macrophage chemotaxis and phagocytosis in pulmonary clearance responses to inhaled particles: comparisons among rodent species.Microsc Res Tech. 1993 Dec 1;26(5):412-22. doi: 10.1002/jemt.1070260509. Microsc Res Tech. 1993. PMID: 8286787
-
The role of macrophages in the clearance of inhaled ultrafine titanium dioxide particles.Am J Respir Cell Mol Biol. 2008 Mar;38(3):371-6. doi: 10.1165/rcmb.2007-0138OC. Epub 2007 Oct 18. Am J Respir Cell Mol Biol. 2008. PMID: 17947511
-
Significance of particle parameters in the evaluation of exposure-dose-response relationships of inhaled particles.Inhal Toxicol. 1996;8 Suppl:73-89. Inhal Toxicol. 1996. PMID: 11542496 Review.
-
Morphological aspects of particle uptake by lung phagocytes.Microsc Res Tech. 2002 Jun 15;57(6):512-22. doi: 10.1002/jemt.10105. Microsc Res Tech. 2002. PMID: 12112434 Review.
-
Barriers that Inhaled Particles Encounter.J Aerosol Med Pulm Drug Deliv. 2024 Oct;37(5):299-306. doi: 10.1089/jamp.2024.27498.bp. J Aerosol Med Pulm Drug Deliv. 2024. PMID: 39388690 Review.
Cited by
-
Impaired mitochondrial function of alveolar macrophages in carbon nanotube-induced chronic pulmonary granulomatous disease.Toxicology. 2020 Dec 1;445:152598. doi: 10.1016/j.tox.2020.152598. Epub 2020 Sep 22. Toxicology. 2020. PMID: 32976959 Free PMC article.
-
Fluoromica nanoparticle cytotoxicity in macrophages decreases with size and extent of uptake.Int J Nanomedicine. 2015 Mar 26;10:2363-75. doi: 10.2147/IJN.S80655. eCollection 2015. Int J Nanomedicine. 2015. PMID: 25848256 Free PMC article.
-
The interplay of lung surfactant proteins and lipids assimilates the macrophage clearance of nanoparticles.PLoS One. 2012;7(7):e40775. doi: 10.1371/journal.pone.0040775. Epub 2012 Jul 10. PLoS One. 2012. PMID: 22802970 Free PMC article.
-
Inhalation of Immuno-Therapeutics/-Prophylactics to Fight Respiratory Tract Infections: An Appropriate Drug at the Right Place!Front Immunol. 2019 Nov 29;10:2760. doi: 10.3389/fimmu.2019.02760. eCollection 2019. Front Immunol. 2019. PMID: 31849954 Free PMC article. Review. No abstract available.
-
Inhaled RNA Therapeutics for Obstructive Airway Diseases: Recent Advances and Future Prospects.Pharmaceutics. 2021 Jan 28;13(2):177. doi: 10.3390/pharmaceutics13020177. Pharmaceutics. 2021. PMID: 33525500 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous